Rexall wins appeal
This article was originally published in The Tan Sheet
Executive Summary
U.S. Federal Circuit Court of Appeals rules Sept. 8 that Rexall Sundown did not infringe on Christian Jansen's patented supplement formula to treat macrocytic-megaloblastic anemia. Rexall markets product containing same combination of folic acid, vitamin B12 as Jansen's product, but makes claims for proper blood homocysteine levels. Jansen appeal stems from an original September 2002 decision ruling in Rexall's favor...
U.S. Federal Circuit Court of Appeals rules Sept. 8 that Rexall Sundown did not infringe on Christian Jansen's patented supplement formula to treat macrocytic-megaloblastic anemia. Rexall markets product containing same combination of folic acid, vitamin B12 as Jansen's product, but makes claims for proper blood homocysteine levels. Jansen appeal stems from an original September 2002 decision ruling in Rexall's favor.... |